Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jul. 31, 2016	Jul. 31, 2015
Operating activities:
Net loss	$ (2,211,909)	$ (2,430,212)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	630,706	625,239
Amortization of capitalized software development costs	1,425,962	1,557,758
Amortization of intangible assets	650,892	674,460
Amortization of other deferred costs	115,113	83,868
Valuation adjustment for warrants liability	(61,856)	(1,268,084)
Share-based compensation expense	909,411	1,283,459
Other valuation adjustments	83,937	94,351
Loss on disposal of property and equipment	567	34,228
Gain on early extinguishment of lease liability	0	(33,059)
Provision for accounts receivable	88,472	89,002
Deferred tax benefit	0	(9,574)
Changes in assets and liabilities, net of effects of acquisitions:
Accounts and contract receivables	357,774	(2,122,715)
Other assets	(214,327)	319,862
Accounts payable	(403,600)	427,914
Accrued expenses	(472,420)	(276,301)
Deferred revenues	(759,411)	1,759,832
Net cash provided by operating activities	139,311	810,028
Investing activities:
Purchases of property and equipment	(60,518)	(117,182)
Capitalization of software development costs	(936,560)	0
Net cash used in investing activities	(997,078)	(117,182)
Financing activities:
Principal repayments on term loan	(2,075,172)	(990,506)
Principal payments on capital lease obligation	(438,962)	(403,701)
Recovery of deferred financing costs	0	2,111
Proceeds from exercise of stock options and stock purchase plan	14,793	207,779
Payments related to settlement of employee shared-based awards	(11,702)	0
Net cash used in financing activities	(2,511,043)	(1,184,317)
Decrease in cash and cash equivalents	(3,368,810)	(491,471)
Cash and cash equivalents at beginning of period	9,882,136	6,522,600
Cash and cash equivalents at end of period	$ 6,513,326	$ 6,031,129